TipRanks
OncoArendi Therapeutics SA (DE:1B1)
FRANKFURT:1B1
Germany Market

OncoArendi Therapeutics SA (1B1) Technical Analysis

0 Followers

Summary of all the Indicators

Overall Consensus
Buy
10Bullish
6Neutral
6Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
OncoArendi Therapeutics SA’s (1B1) Moving Averages Convergence Divergence (MACD) indicator is 0.08, suggesting OncoArendi Therapeutics SA is a Buy.
OncoArendi Therapeutics SA’s (1B1) 20-Day exponential moving average is 1.57, while OncoArendi Therapeutics SA’s (1B1) share price is €1.16, making it a Sell.
OncoArendi Therapeutics SA’s (1B1) 50-Day exponential moving average is 1.46, while OncoArendi Therapeutics SA’s (1B1) share price is €1.16, making it a Buy.

OncoArendi Therapeutics SA (1B1) Pivot Points

Sep 28, 2026, 05:44 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.62
1.62
1.62
1.62
1.62
1.62
1.62
Fibonacci
1.62
1.62
1.62
1.62
1.62
1.62
1.62
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

OncoArendi Therapeutics SA (1B1) Moving Averages

Sep 28, 2026, 05:44 PM
Period
Simple
Exponential
MA5
1.68Sell
1.64Sell
MA10
1.68Sell
1.64Sell
MA20
1.54Buy
1.57Sell
MA50
1.42Buy
1.46Buy
MA100
1.35Buy
1.41Buy
MA200
1.43Buy
1.46Buy
OncoArendi Therapeutics SA’s (1B1) 10-Day exponential moving average is 1.64, while OncoArendi Therapeutics SA’s (1B1) share price is €1.16, making it a Sell.
OncoArendi Therapeutics SA’s (1B1) 100-Day exponential moving average is 1.41, while OncoArendi Therapeutics SA’s (1B1) share price is €1.16, making it a Buy.
OncoArendi Therapeutics SA’s (1B1) stock price is €1.16 and OncoArendi Therapeutics SA’s (1B1) 50-day simple moving average is 1.42, creating a Buy signal.
OncoArendi Therapeutics SA’s (1B1) stock price is €1.16 and OncoArendi Therapeutics SA’s (1B1) 100-day simple moving average is 1.35, creating a Buy signal.
OncoArendi Therapeutics SA’s (1B1) stock price is €1.16 and OncoArendi Therapeutics SA’s (1B1) 200-day simple moving average is 1.43, creating a Buy signal.

OncoArendi Therapeutics SA (1B1) Technical Indicators

Sep 28, 2026, 05:44 PM
Name
Value
Implied Action
RSI (14)
52.43
Neutral
STOCH (9,6)
26.07
Neutral
STOCHRSI (14)
54.45
Neutral
MACD (12,26)
0.08
Buy
ADX (14)
26.16
Neutral
Williams %R
-62.09
Buy
CCI (14)
12.80
Neutral
ATR (14)
0.05
-
Ultimate Oscillator
49.74
Neutral
ROC
13.77
Buy
OncoArendi Therapeutics SA’s (1B1) Relative Strength Index (RSI) is 52.43, creating a Neutral signal.
OncoArendi Therapeutics SA’s (1B1) Trend Strength Indicator (ADX) is 26.16, creating a Neutral signal.
OncoArendi Therapeutics SA’s (1B1) Commodity Channel Index (CCI) is 12.80, creating a Neutral signal.
OncoArendi Therapeutics SA’s (1B1) Price Rate of Change (ROC) is 13.77, creating a Buy signal.

FAQ

Is 1B1 a Buy, Hold, or Sell?
Based on 1B1’s technical indicators, 1B1 is a Buy.
    What is 1B1’s RSI (14)?
    1B1’s RSI (14) is 52.43, which suggests 1B1 is a Neutral.
      What is 1B1’s MACD?
      1B1’s MACD is 0.08, which suggests 1B1 is a Buy.
        What is 1B1’s 5-day moving average?
        1B1’s 5-day moving average is 1.68, which suggests 1B1 is a Sell.
          What is 1B1’s 20-day moving average?
          1B1 20-day moving average is 1.54, which suggests 1B1 is a Buy.
            What is 1B1’s 50-day moving average?
            1B1’s 50-day moving average is 1.42, which suggests 1B1 is a Buy.
              What is 1B1’s 200-day moving average?
              1B1’s 200-day moving average is 1.43, which suggests 1B1 is a Buy.
                What is 1B1’s Williams % R (14)?
                1B1’s Williams % R (14) is -62.09, which suggests 1B1 is a Buy.
                  What is 1B1’s CCI (14)?
                  1B1’s CCI (14) is 12.80, which suggests 1B1 is a Neutral.
                    What is the share price of OncoArendi Therapeutics SA?